Wen-Juei Jeng

48PUBLICATIONS
71CO-AUTHORS
Gene and molecular therapyBehavioural epidemiologyHaematological tumoursHaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 20, 2026
A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs.

|Jul 02, 2025
Switching to Entecavir >3 Months Before the End of Tenofovir-Based Therapy in Hepatitis B e Antigen-Negative Patients May Reduce Early Relapse and Hepatitis Flare.

Yi-Cheng Chen, Wen-Juei Jeng, Rong-Nan Chien

|Jan 17, 2025
Higher Relapse Rate in HBeAg-Negative Patients After Cessation of Tenofovir Alafenamide Compared With Entecavir or Tenofovir Disoproxil Fumarate.

Hsin-Wei Fang, Wen-Juei Jeng, Tsung-Hui Hu

|Sep 28, 2024
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents.

Yu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng

|Mar 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).

Grishma Hirode, Bettina E Hansen, Chien-Hung Chen

|Feb 27, 2024
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.

Hsin-Che Lin, Wen-Juei Jeng, Jessica Liu

Pageof 8

Frequent Collaborators

13 joint publications

Yun-Fan Liaw

10 joint publications

Yen-Chun Liu

8 joint publications

Rong-Nan Chien

5 joint publications

Hwai-I Yang